The Need for Precision Therapies as Determined by Genetic Signature for Cystic Fibrosis

The Need for Precision Therapies as Determined by Genetic Signature for Cystic Fibrosis

Cystic fibrosis (CF) is a devastating genetic infant-onset disease [...]

Bibliographic Details
Main Author:	Farah R. Zahir
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Journal of Personalized Medicine
Subjects:	n/a
Online Access:	https://www.mdpi.com/2075-4426/11/12/1353

Similar Items

Newborn Screening for Cystic Fibrosis: Over the Hump, Still Need to Fine-Tune It
by: Carlo Castellani
Published: (2020-07-01)

Clinical Advances in Cystic Fibrosis
by: Esther Imperlini, et al.
Published: (2022-10-01)

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
by: Nicoletta Pedemonte
Published: (2020-09-01)

Editorial on the Paper “The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis” by Butler, Alghoubayshi and Roman
by: Farah R. Zahir
Published: (2022-08-01)

Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes
by: Sébastien Boutin, et al.
Published: (2023-04-01)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
by: Jürg Barben, et al.
Published: (2020-07-01)

Progressions in Cardiac Arrhythmia: Specific Populations and the Need for Precision Medicine
by: José Miguel Rivera-Caravaca, et al.
Published: (2023-07-01)

Special Issue: “Genetic Counseling and Genetic Testing in Precision Medicine”
by: Erin Turbitt, et al.
Published: (2023-07-01)

Heart Failure with Preserved Ejection Fraction: An Urgent Need for Precision Medicine
by: Gema Miñana, et al.
Published: (2021-04-01)

Cystic Fibrosis, New Frontier: Exploring the Functional Connectivity of the Brain Default Mode Network. Comment on Elce et al. Impact of Physical Activity on Cognitive Functions: A New Field for Research and Management of Cystic Fibrosis. <i>Diagnostics</i> 2020, <i>10</i>, 489
by: Simone Gambazza, et al.
Published: (2021-05-01)

Inherited Cancer Genetic Epidemiology to Improve Precision Medicine
by: Pål Møller, et al.
Published: (2022-02-01)

The Urgent Need for Precision Medicine in Cancer and Its Microenvironment: The Paradigmatic Case of Multiple Myeloma
by: Antonio Giovanni Solimando, et al.
Published: (2022-09-01)

Reply to Gambazza et al. Cystic Fibrosis, New Frontier: Exploring the Functional Connectivity of the Brain Default Mode Network. Comment on “Elce et al. Impact of Physical Activity on Cognitive Functions: A New Field for Research and Management of Cystic Fibrosis. <i>Diagnostics</i> 2020, <i>10</i>, 489”
by: Ausilia Elce, et al.
Published: (2021-05-01)

Gene therapy for cystic fibrosis: new tools for precision medicine
by: Jin-A Lee, et al.
Published: (2021-10-01)

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy
by: Afua Adjeiwaa Mensah, et al.
Published: (2022-10-01)

Innovative Therapies in Genetic Diseases: Cystic Fibrosis
by: Elena-Silvia Shelby, et al.
Published: (2021-03-01)

Unraveling the Genetic and Epigenetic Complexities of Hereditary Aortic Diseases and the Breakthroughs of Precision Medicine: An Editorial
by: Fares Awa, et al.
Published: (2023-07-01)

Pulmonary Arterial Hypertension in Genetic and Comorbid Settings: A Step Forward for Precision Medicine
by: Rosalinda Madonna
Published: (2022-11-01)

Maintaining Respiratory Health in Cystic Fibrosis Patients
by: MR Modaresi
Published: (2014-04-01)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
by: Montemari AL, et al.
Published: (2022-10-01)

Correction: Dagenais et al. Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. <i>J. Clin. Med.</i> 2021, <i>10</i>, 23
by: Renée V. E. Dagenais, et al.
Published: (2022-01-01)

Glioblastoma Biology, Genetics and Possible Therapies
by: Javier S. Castresana, et al.
Published: (2023-08-01)

Evolving Nutritional Needs in Cystic Fibrosis
by: Theresa Frantzen, et al.
Published: (2023-06-01)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
by: Ruchi Yadav, et al.
Published: (2023-09-01)

Genetic screening in cystic fibrosis
by: Chmiel James F, et al.
Published: (2001-03-01)

Precision Management of Fruit Trees
by: Riccardo Lo Bianco, et al.
Published: (2022-12-01)

Biomarkers in the Era of Precision Oncology
by: Constantin N. Baxevanis
Published: (2023-03-01)

Personalized and Precision Medicine 2022
by: Anne-Marie Caminade
Published: (2023-03-01)

Precision Medicine in Radiomics and Radiogenomics
by: Serena Monti
Published: (2022-11-01)

Future therapies for cystic fibrosis
by: Lucy Allen, et al.
Published: (2023-02-01)

Evolution of Epigenetic Mechanisms and Signatures
by: Alla Kalmykova, et al.
Published: (2022-12-01)

Cancer Evolution in Precision Medicine Era
by: Dimitris Karagiannis, et al.
Published: (2022-04-01)

Translational, Precision, and Personalized Medicine in Gastroenterology
by: Marcello Candelli
Published: (2022-07-01)

Model-Informed Precision Dosing (MIPD)
by: Jonás Samuel Pérez-Blanco, et al.
Published: (2022-12-01)

Recent Advancements in Precision Livestock Farming
by: Gang Liu, et al.
Published: (2023-08-01)

Precision Bariatric/Metabolic Medicine and Surgery
by: Laurent Genser, et al.
Published: (2023-02-01)

Precision Medicine in Sepsis and Septic Shock
by: Alejandro Suarez-de-la-Rica, et al.
Published: (2022-09-01)

Precision Agriculture: Strategies and Technology Adoption
by: Gonçalo C. Rodrigues
Published: (2022-09-01)

Precision Medicine in Vascular and Endovascular Surgery
by: Fadi Taher, et al.
Published: (2023-01-01)

Special Issue on Precision Dimensional Measurements
by: Kuang-Chao Fan, et al.
Published: (2019-08-01)